Health Plan of San Joaquin Hosts Two Trainings for Opioids Treatment for HPSJ’s Provider Network
FREE CMEs + CEs
MAT Waiver TRAINING & Online Component
Science and Practice of Treating Patients with Pain and OUD TRAINING
- (4.25 hours live) Saturday, March 9, 8:30 AM – 1:00 PM (PT)
- (3.75 hours online) – Within 30 days after the March 9th training
Science and Practice of Treating Patients with Pain and OUD
- (3 hours live) Saturday, March 9, 2:00 PM – 5:15 PM (PT)
Presenter Brian Hurley, MD, MBA, DFASAM, will review the Providers Clinical Support System (PCSS) MAT Waiver Training sponsored by the American Academy of Addiction Psychiatry (AAAP). The link to the remaining 3.75 hours of online training will be emailed to attendees following the March 9th event.
Dr. Hurley also represents State Targeted Response Technical Assistance (STR-TA) & UCLA Integrated Substance Abuse Programs to train providers in treating pain and opioid use disorder (OUD).
These trainings are especially relevant for physicians, physician assistants, nurse practitioners, and behavioral health counselors.
Space is limited to 70 attendees. RSVP by February 22th
For more about these trainings, see the HPSJ Provider Alert (December 14, 2018). Breakfast, lunch, and coffee will be served March 9.
Opioids – Patient Safety and Pain Management
According to the 2016 Morbidity and Mortality Weekly Report on Increases in Drug and Opioid- Involved Overdose Deaths, drug-related deaths nearly tripled from 1999 to 2014. In 2014, 60.9 percent of drug overdose deaths involved an opioid.
The published data showed that from 2014 to 2015, other synthetic opioid deaths increased 72.2 percent and natural/semisynthetic opioid deaths increased by 2.6 percent.
These numbers are alarming. This trend can be reversed and the safety of patients can be maintained. To tackle this nationwide problem, utilization of the following resources is key.
Figure 1: Although there are several different analysis strategies for opioid overdose deaths, all show there is an upward trend in deaths. However, these are likely underestimates because many overdose deaths do not specify the drug(s) involved.
Links & Resources
- CDC Guideline for Prescribing Opioids for Chronic Pain:
- UCSF Substance Use Management Clinician Consultation:
- Substance Use Warmline: 855.300.3595
– Peer-to-peer consultation from physician, clinical pharmacists and nurses
– Monday -Friday, 10 a.m. – 6 p.m., EST
- Substance Use Warmline: 855.300.3595
- SAMHSA Opioid Treatment Program Directory:
- American Pain Society Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain: http://www.jpain.org/article/S1526-5900(08)00831-6/pdf
- Medical Board of California Guidelines for Prescribing Controlled Substances for Pain:5. Medical Board of California Guidelines for Prescribing Controlled Substances for Pain: http://www.mbc.ca.gov/licensees/prescribing/pain_guidelines.pdf
- CURES 2.0: https://cures.doj.ca.gov
- Opioid Risk Assessment Tool: https://www.drugabuse.gov/sites/default/files/files/OpioidRiskTool.pdf
- National Institute on Drug Abuse Opioid Prescribing Resources: https://www.drugabuse.gov/nidamed-medical-health-professionals/tool-resources-your-practice/opioid-prescribing-resources
- SMARTCARE California:
- Curbing the Opioid Epidemic checklist: http://www.chcf.org/~/media/MEDIA%20 LIBRARY%20Files/PDF/PDF%20H/PDF%20 HealthPlansOpioidChecklist.pdf
- Resources for Opioid Prescribers: https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/SACB/CDPH%20Document%20Library/OpioidPrescribersResources.pdf
- California Health Care Foundation: Understanding the Epidemic Through Data: The California Opioid Overdose Surveillance Dashboard- https://pdop.shinyapps.io/ODdash_v1/
- Food and Drug Administration MedWatch Safety Alerts for Human Medical Products: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/default.htm
1 FDA Drug Safety Communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. U.S. Food and Drug Administration Web Site. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116839.htm. Updated April 20, 2017. Accessed May 1, 2017.
Posted on October 26th, 2017 and last modified on February 13th, 2019.